AYOXXA - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79224525
Serial Number
79224525
Registration Number
5705785
Word Mark
AYOXXA
Status
700 - Registered
Status Date
2019-03-26
Filing Date
2017-10-06
Registration Number
5705785
Registration Date
2019-03-26
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2019-01-08
Attorney Name
Joyce von Natzmer
Law Office Assigned Location Code
N70
Employee Name
BERLIN, JUSTIN E
Statements
Goods and Services
Pharmaceutical preparations for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; veterinary pharmaceutical preparations for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations; diagnostic agents for medical purposes; diagnostic agents for veterinary purposes; chemical and biochemical preparations for medical purposes, namely, for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; chemical and biochemical reagents for medical purposes; chemical and biochemical preparations for veterinary purposes, namely, for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations; chemical and biochemical reagents for veterinary purposes; chemical and biochemical preparations for pharmaceutical purposes, namely, for treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases; chemical and biochemical reagents for medical or veterinary pharmaceutical purposes; biological agents for laboratory analyses for medical purposes, namely, peptides, proteins and nucleic acids used as diagnostic agents for medical purposes; biological agents for laboratory analyses for veterinary purposes, namely, peptides, proteins and nucleic acids used as diagnostic agents for veterinary purposes; chemical and biochemical preparations and reagents for medical purposes, namely, for use in DNA analyses; chemical and biochemical preparations for blood tests for medical purposes; chemical and biochemical reagents for blood tests for medical purposes; chemical and biochemical preparations for blood tests for veterinary purposes; chemical and biochemical reagents for blood tests for veterinary purposes; peptides, proteins, nucleic acids and other biomolecules, or complexes of these molecules, for medical purposes, namely, synthetic or natural peptides, proteins, allergens, metabolites or nucleic acids for the treatment and prevention of cancer, treatment and prevention of inflammatory diseases, treatment and prevention of autoimmune diseases, treatment and prevention of cardiovascular diseases, treatment and prevention of ophthalmic diseases, treatment and prevention of gastro-intestinal diseases, and treatment and prevention of neurologic diseases, protein arrays for medical diagnosis purposes, nucleic acid sequences for medical diagnosis purposes; proteins, nucleic acids and other biomolecules, or complexes of these molecules, for veterinary purposes, namely, synthetic or natural peptides, proteins, allergens, metabolites or nucleic acids for treatment of gastro-intestinal diseases, treatment of inflammatory diseases, treatment of ophthalmic diseases, and treatment of mucosa irritations in animals, protein arrays for veterinary diagnosis purposes, nucleic acid sequences for veterinary diagnosis purposes; chemical and biochemical preparations and reagents for labelling of molecules for medical detection and monitoring purposes; chemical and biochemical preparations and reagents for labelling of molecules for veterinary detection and monitoring purposes
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-01-10
Primary Code
005
Current Trademark Owners
Party Name
AyoxxA Biosystems GmbH
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited liability company (GmbH)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
AyoxxA Biosystems GmbH
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited liability company (GmbH)).
Address
Please log in with your Justia account to see this address.
Party Name
AyoxxA Biosystems GmbH
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Limited liability company (GmbH)).
Address
Please log in with your Justia account to see this address.
Party Name
AyoxxA Biosystems GmbH
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Limited liability company (GmbH)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Joyce von Natzmer
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1383660
International Registration Date
2017-10-06
International Publication Date
2018-01-04
International Renewal Date
2027-10-06
Auto Protection Date
2019-07-04
International Status
001 - Request for extension of protection established
International Status Date
2018-01-04
Priority Claimed In
True
Priority Claimed Date
2017-04-07
First Refusal In
True
Trademark Events
Event DateEvent Description
2018-01-04SN ASSIGNED FOR SECT 66A APPL FROM IB
2018-01-10NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-01-16APPLICATION FILING RECEIPT MAILED
2018-01-16ASSIGNED TO EXAMINER
2018-02-06NON-FINAL ACTION WRITTEN
2018-02-07NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2018-02-16NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
2018-03-21NON-FINAL ACTION WRITTEN
2018-03-22NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2018-03-22REFUSAL PROCESSED BY MPU
2018-03-22NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2018-04-06REFUSAL PROCESSED BY IB
2018-09-21TEAS RESPONSE TO OFFICE ACTION RECEIVED
2018-09-21CORRESPONDENCE RECEIVED IN LAW OFFICE
2018-09-21TEAS/EMAIL CORRESPONDENCE ENTERED
2018-10-22ASSIGNED TO EXAMINER
2018-11-14APPROVED FOR PUB - PRINCIPAL REGISTER
2018-12-19NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-01-08PUBLISHED FOR OPPOSITION
2019-01-08OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-03-26REGISTERED-PRINCIPAL REGISTER
2019-06-26FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2019-07-25FINAL DISPOSITION PROCESSED
2019-07-25FINAL DISPOSITION NOTICE SENT TO IB
2019-08-16FINAL DECISION TRANSACTION PROCESSED BY IB
2019-11-01NEW REPRESENTATIVE AT IB RECEIVED